UK-ISRAEL Hemato-Oncology 2018 Dotan symposium

UK-ISRAEL Hemato-Oncology 2018 Dotan symposium
  • About
  • Program
  • General Information
  • Registration

Varda and Boaz Dotan have founded a unique center in Tel Aviv University. Their generous donation has fostered advanced research of hematological malignancies bringing together physicians and scientists in Tel Aviv University and in the affiliated university hospitals. The ultimate goal of this translational research is to harness biology for the cure of hematological malignancies.


The third international Dotan’s Symposium of hematological malignancies is a special symposium bringing together some of the best translational researchers of hematological malignancies in the UK and Israel.  This has been possible thanks to initiative by Prof Paresh Vyas from Oxford and the support of the UK Academic Study Group on Israel and the Middle East. The lectures will cover the state-of-the-art of research of hematopoietic stem cells and their niche, lymphoid and myeloid malignancies. The goal is to foster collaborations between Israeli and UK to promote the cure of hematological cancers.


Shai Izraeli, MD
Head, the Varda and Boaz Dotan Center for Hemato-Oncology Research
The Dora and Giorgio Professor of Hematological Malignancies
Tel Aviv University
Head, the Rina Zaizov Division of Pediatric Hematology and Oncology, Schneider Children’s Medical Center of Israel.
Paresh Vyas FRCP, FRCPath, DPhil,
Professor of Haematology and Consultant Haematologist
MRC Molecular Haematology Unit and Department of Haematology
Weatherall Institute of Molecular Medicine
University of Oxford and Oxford University Hospitals NHS Trust, Oxford OX3 9DS, United Kingdom.
Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive